drugset / Trial / NCT00059722

This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

NCT00059722

Phase 2 Completed 160 enrolled Genzyme, a Sanofi Company
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to compare the efficacy of ZD6474 and ZD1839 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.

Timeline

Start
2003-05
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefitinib Small molecule
Subject Vandetanib Small molecule